The 2015 Novo Nordisk Prize Symposium on

The 2015 Novo Nordisk Prize Symposium on Hepatitis C Virus (HCV)
Friday the 11th of September, 2015
Lecture Hall, Novo Nordisk Foundation, Tuborg Havnevej 19, DK-2900 Hellerup, Denmark
Organized by Prof. Jens Bukh, Copenhagen Hepatitis C Program (CO-HEP) and CEO Birgitte Nauntofte, Novo Nordisk Foundation
8.30
Registration
9.00
Welcome - The 2015 Novo Nordisk Prize
Niels-Henrik von Holstein-Rathlou, CSO, Novo Nordisk Foundation
9.15
From Non-A, Non-B to hepatitis C virus – a historical perspective from the mentor
Robert Purcell, National Institutes of Health, Bethesda, Maryland, USA
9.45
Infectious culture systems of hepatitis C virus – years in the making
Jens Bukh, CO-HEP
10.15
How have humanized mice contributed to our understanding of HCV
Philip Meuleman, Ghent University, Ghent, Belgium
10.50
Coffee/tea
11.15
The long journey of hepatitis C virus entry into the hepatocyte
Jean Dubuisson, Institut Pasteur, Lille, France
11.50
A new view of virus-microRNA interactions: HCV, miR-122, and beyond
Charles Rice, The Rockefeller University, New York, New York, USA
12.25
Viral and host factors in HCV-associated hepatocellular carcinoma
Patrizia Farci, National Institutes of Health, Bethesda, Maryland, USA
13.00
Lunch
13.45
Cell culture studies of direct acting antivirals against HCV
Judith Gottwein, CO-HEP
14.20
Specificity of the protective B cell response to HCV
Steven Foung, Stanford University Blood Center, Palo Alto, California, USA
14.55
Role of CD8+ T cell responses in HBV and HCV infection
Robert Thimme, University Hospital of Freiburg, Freiburg, Germany
15.30
Coffee/tea
15.55
Hepatitis C virus neutralizing epitopes and rational vaccine design
Mansun Law, The Scripps Research Institute, La Jolla, California, USA
16.30
Comparing immunity against hepatitis viruses: what can be learned from studies of HAV and HEV Christopher Walker, The
Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA
17.05
Closing remarks
Jens Bukh, CO-HEP
17.15
End of program